NGL Fine Chem Ltd

Product Portfolio
Presently, Veterinary APIs is the main product of the company which account for 89% of its revenues, followed by Veterinary Formulations (5%), Human APIs (2%), Intermediates (2%) & Others (2%). ^# The company has been able to increase its market share in the lower share of its portfolio which has increased to the levels of 50-60%. ^#

Manufacturing Facilities
The company has 3 manufacturing facilities which are located at Tarapur & Navi Mumbai in Maharashtra. ^# It commenced the commercial production of its brownfield expansion at Tarapur facility in Feb 2019. ^# The company has been able to increase it capacity utilization levels from 60-70% to 90+% since the last year. ^{# #}

Geographical Presence
The company has a global presence with operations in more than 40 countries. It earns about 75% of its revenues from exports while the rest 25% revenues come from domestic sales. Its international markets include Europe, Asia Pacific, Middle East and Latin America. ^# Presently, it has a clientele base of ~400 clients from across the world. ^#

Acquisition of Macrotech Polychem
The company completed the acquisition of Macrotech Polychem Pvt Ltd in FY20 for a cash consideration of 7 crores. ^# It owns a manufacturing plant near to the company's plant and is involved in the manufacturing of pharmaceutical intermediaries. ^#

Expansion Plans
The company plans a normal CAPEX which basically consists of debottlenecking the plant which increases the capacity by 10-15% per year till the next 2 years until the new capacity from greenfield expansion comes on stream. ^#